Literature DB >> 11454659

Role of the extracellular signal-regulated kinase (Erk) signal transduction cascade in alpha(2) adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein.

R E Roberts1.   

Abstract

The mechanism of alpha(2) adrenoceptor-mediated vasoconstriction is unknown, but may involve activation of voltage-sensitive calcium channels, and/or a protein tyrosine kinase. Recently the extracellular signal-regulated kinase (Erk) cascade, often an event downstream of tyrosine kinase activation, has been shown to mediate vasoconstriction to a variety of agents. The aim of this present study was to determine the involvement of the Erk signal transduction cascade in alpha(2) adrenoceptor-mediated vasoconstriction, and to confirm the involvement of activation of voltage-sensitive calcium channels, and protein tyrosine kinase. Contractions to the alpha(2) adrenoceptor agonist UK14304 in the porcine palmar lateral vein in vitro were reduced 70 - 80% by the MEK inhibitors PD98059 (10 - 50 microM) and U0126 (10 - 50 microM), indicating the involvement of the Erk signal transduction cascade. Immunoblots also demonstrated an increase in the phosphorylated (activated) form of Erk in palmar lateral vein segments after contraction with UK14304, which was inhibited by PD98059 and U0126. The calcium channel blockers nifedipine and verapamil, or removal of extracellular calcium inhibited UK14304-induced contractions and phosphorylation of Erk, demonstrating the importance of an influx of extracellular calcium. UK14304-induced contractions were inhibited by PP2 (1 - 10 microM), a selective inhibitor of Src tyrosine kinases, but not by PP3, an inactive analogue. PP2 also prevented the phosphorylation of Erk by UK14304. These data demonstrate that alpha(2) adrenoceptor-mediated vasoconstriction in the porcine palmar lateral vein is dependent upon activation of the Erk signal transduction cascade, which is downstream of an influx of extracellular calcium, and activation of Src tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454659      PMCID: PMC1572855          DOI: 10.1038/sj.bjp.0704149

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Nonspecific inhibition of myogenic tone by PD98059, a MEK1 inhibitor, in rat middle cerebral arteries.

Authors:  G J Lagaud; E Lam; A Lui; C van Breemen; I Laher
Journal:  Biochem Biophys Res Commun       Date:  1999-04-13       Impact factor: 3.575

Review 2.  Alpha-adrenoceptors: a critical review.

Authors:  J C McGrath; C M Brown; V G Wilson
Journal:  Med Res Rev       Date:  1989 Oct-Dec       Impact factor: 12.944

Review 3.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

4.  UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor subtypes.

Authors:  D Cambridge
Journal:  Eur J Pharmacol       Date:  1981-07-10       Impact factor: 4.432

5.  Effect of forskolin on cytosolic Ca++ level and contraction in vascular smooth muscle.

Authors:  A Abe; H Karaki
Journal:  J Pharmacol Exp Ther       Date:  1989-06       Impact factor: 4.030

6.  Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.

Authors:  A Banes; J A Florian; S W Watts
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

7.  Tyrosine kinases of the Src family participate in signaling to MAP kinase from both Gq and Gi-coupled receptors.

Authors:  T Igishi; J S Gutkind
Journal:  Biochem Biophys Res Commun       Date:  1998-03-06       Impact factor: 3.575

8.  Dihydropyridine-sensitive low-threshold calcium channels in isolated rat hypothalamic neurones.

Authors:  N Akaike; P G Kostyuk; Y V Osipchuk
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

9.  Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.

Authors:  H J Motulsky; M D Snavely; R J Hughes; P A Insel
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

10.  Identification of a novel inhibitor of mitogen-activated protein kinase kinase.

Authors:  M F Favata; K Y Horiuchi; E J Manos; A J Daulerio; D A Stradley; W S Feeser; D E Van Dyk; W J Pitts; R A Earl; F Hobbs; R A Copeland; R L Magolda; P A Scherle; J M Trzaskos
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

View more
  12 in total

1.  Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta.

Authors:  T Matsumoto; T Kobayashi; K Kamata
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

2.  Phytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cells.

Authors:  Srivatcha Naragoni; Shireesha Sankella; Kinesha Harris; Wesley G Gray
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

3.  Src family kinase involvement in rat preglomerular microvascular contractile and [Ca2+]i responses to ANG II.

Authors:  Qi Che; Pamela K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-30

4.  Enhancement of alpha2-adrenoceptor-mediated vasoconstriction by the thromboxane-mimetic U46619 in the porcine isolated ear artery: role of the ERK-MAP kinase signal transduction cascade.

Authors:  B Bhattacharya; R E Roberts
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 5.  Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors.

Authors:  Elfaridah P Frazier; Stephan L M Peters; Alan S Braverman; Michael R Ruggieri; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-04       Impact factor: 3.000

6.  Effect of inhibition of extracellular signal-regulated kinase on relaxations to beta-adrenoceptor agonists in porcine isolated blood vessels.

Authors:  C O Uhiara; S P H Alexander; R E Roberts
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

7.  Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine.

Authors:  Christoph Altmann; Veronika Steenpass; Peter Czyborra; Peter Hein; Martin C Michel
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  Alpha 2 adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein: role of phosphatidylinositol 3-kinase and EGF receptor transactivation.

Authors:  R E Roberts
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

9.  Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK.

Authors:  T Kobayashi; T Nogami; K Taguchi; T Matsumoto; K Kamata
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

10.  c-Jun NH₂-terminal kinase contributes to dexmedetomidine-induced contraction in isolated rat aortic smooth muscle.

Authors:  Seong-Ho Ok; Young Seok Jeong; Jae-Gak Kim; Seung-Min Lee; Hui-Jin Sung; Hye Jung Kim; Ki Churl Chang; Seong-Chun Kwon; Ju-Tae Sohn
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.